Brief: Hofseth Biocare Q2 EBITDA Loss Narrows To NOK 8.4 Million
30/08/2019 16:02
Aug 30 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q2 SALES REVENUE NOK 12.8 MILLION VERSUS NOK 14.6 MILLION YEAR AGO
* Q2 EBITDA LOSS NOK 8.4 MILLION VERSUS LOSS NOK 12.9 MILLION YEAR AGO
Source text for Eikon: ID:nGNE9pKTPr
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: Hofseth BioCare Board Member Buys 2.5 Mln Shares in Company
Brief: Hofseth Biocare Appoints Leif Arne Giske As CFO
Hofseth BioCare Q2 operating revenue slips on lower raw material volumes
Brief: Hofseth Biocare Q2 Revenue NOK 65.7 Million
Brief: Research Corporation Buys 14.3 Mln Shares In Hofseth Biocare